Evidence map›Paper›PMID 29226078›Full record

ArticleFEBS open bio2017

Identification and

Hannah Berberich, Felix Terwesten, Sinja Rakow, Peeyush Sahu, Caroline Bouchard, Marion Meixner, Sjaak Philipsen, Peter Kolb, Uta-Maria Bauer

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Hannah BerberichInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Felix TerwestenInstitute of Pharmaceutical Chemistry Philipps-University Marburg Germany.
Sinja RakowInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Peeyush SahuInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Caroline BouchardInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Marion MeixnerInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Sjaak PhilipsenDepartment of Cell Biology Erasmus MC Rotterdam The Netherlands.
Peter KolbInstitute of Pharmaceutical Chemistry Philipps-University Marburg Germany.
Uta-Maria BauerInstitute of Molecular Biology and Tumor Research (IMT) Philipps-University Marburg Germany.
Philipps University of Marburg · DEInstitute of Molecular Biology · DEErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein arginine methyltransferase 4 (PRMT4) is an essential epigenetic regulator of fundamental and conserved processes during vertebrate development, such as pluripotency and differentiation. Surprisingly, PRMT4 homologs have been identified in nearly all vertebrate classes except the avian genome. This raises the possibility that in birds PRMT4 functions are taken over by other PRMT family members. Here, we reveal the existence of a

Indexed as

epigenetic regulationhistone arginine methylationhomology modelingPleckstrin homology domainprotein arginine methyltransferase 4protein–protein docking

Identifiers

PMID29226078
PMCPMC5715347
OpenAlexW2756647753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.